Amgen Inc Revenue per Employee (AMGN), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Amgen Inc   (NASDAQ: AMGN)
 

Amgen Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 9.53% in the second quarter 2026, year on year to cumulative value of $38,095 million, Amgen Inc 's revenue per employee grew on a trailing twelve months basis to $ 2,930,385, this marks a new company high.
Within the Healthcare sector Employees of 20 other companies have achieved higher revenue per employee. While Amgen Inc 's total ranking has deteriorated compared to the previous quarter from 79 to 314. Amgen Inc has 13,000 employees.


What is Sales per Employee Ratio?







AMGN Revenue per Employee (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Revenue Change 9.53 % 5.76 % 8.58 % 12.4 % 9.43 %
Sales per Employee (TTM) $ 2,930,385 2,863,077 2,827,000 2,767,000 2,685,923
AMGN's Total Ranking # 314 # 79 # 0 # 0 # 0
Seq. Revenue Change 16.66 % -12.65 % 3.23 % 4.12 % 12.64 %


Revenue per Employee Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 3
Healthcare Sector # 21
Overall Market # 314

Revenue per Employee Statistics
High Average Low
$ 2,930,385 $ 1,653,219 $ 928,308
(Jun 30 2026)   (Sep. 30, 2005)



Financial Statements
Amgen Inc 's Revenue MRQ $ 10,054 Millions Visit AMGN's Income Statement
Amgen Inc 's Revenues TTM $ 38,095 Millions Visit AMGN's aggregate revenue growth
What are AMGN's Sales? Visit AMGN's Sales by Segment




Other Ratios
Amgen Inc 's Income per Employee
Employees in Biotechnology & Pharmaceuticals
Biotechnology & Pharmaceuticals Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
AMGN's Revenue per Employee versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for AMGN's Competitors
Revenue per Employee for AMGN's Suppliers
Revenue per Employee for AMGN's Customers

You may also want to know
AMGN's Sales Growth Rates AMGN's Pe Price to earnings ratio AMGN's Receivables Turnover Ratio AMGN's Stock Quote
AMGN's Net Income Growth Rates AMGN's Ps Price to Sales ratio AMGN's Sales per Employee AMGN's Asset Turnover Ratio
AMGN's Net Margin AMGN's Pb Price to Book ratio AMGN's Financial Strength Ratios AMGN's Dividend Payout Ratio
Date modified: 2026-09-13T23:23:44+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
P3 Health Partners Inc   4,696,368.75 $ 1,502.838  Million 320 
Nuvation Bio Inc   3,943,046.51 $ 169.551  Million 43 
Halozyme Therapeutics Inc   3,933,186.76 $ 1,663.738  Million 423 
Ironwood Pharmaceuticals inc   3,893,160.00 $ 389.316  Million 100 
Community Health Systems Inc   3,865,483.87 $ 11,983.000  Million 3,100 
Vaxart Inc   3,739,446.15 $ 243.064  Million 65 
Illumina Inc   3,510,156.25 $ 4,493.000  Million 1,280 
Harmony Biosciences Holdings inc   3,277,102.39 $ 960.191  Million 293 
Therapeuticsmd Inc   3,270,000.00 $ 3.270  Million 1 
Amgen Inc   2,930,384.62 $ 38,095.000  Million 13,000 
Innoviva Inc   2,645,471.70 $ 420.630  Million 159 
Aurinia Pharmaceuticals Inc   2,433,648.44 $ 311.507  Million 128 
Eton Pharmaceuticals Inc   2,392,704.55 $ 105.279  Million 44 
Cormedix Inc   2,366,196.28 $ 451.943  Million 191 
Sarepta Therapeutics Inc   2,364,483.83 $ 1,974.344  Million 835 
United Therapeutics Corporation  2,253,214.29 $ 3,154.500  Million 1,400 
Biocryst Pharmaceuticals Inc   2,162,328.74 $ 940.613  Million 435 
Elite Pharmaceuticals Inc   2,155,839.86 $ 140.130  Million 65 
Protagonist Therapeutics inc   2,136,303.03 $ 281.992  Million 132 
Exelixis Inc   2,123,731.47 $ 2,435.920  Million 1,147 
Zevra Therapeutics Inc   2,112,377.05 $ 128.855  Million 61 
Liquidia Corporation  2,087,532.41 $ 450.907  Million 216 
Tg Therapeutics Inc   2,003,849.62 $ 799.536  Million 399 
Prestige Consumer Healthcare Inc   1,938,521.05 $ 1,104.957  Million 570 
Privia Health Group Inc   1,923,384.18 $ 2,358.069  Million 1,226 
Alnylam Pharmaceuticals Inc   1,921,672.80 $ 4,804.182  Million 2,500 
Gilead Sciences Inc   1,791,588.24 $ 30,457.000  Million 17,000 
Collegium Pharmaceutical Inc   1,777,172.58 $ 751.744  Million 423 
Fennec Pharmaceuticals Inc   1,692,028.57 $ 59.221  Million 35 
Neurocrine Biosciences Inc   1,686,950.00 $ 3,373.900  Million 2,000 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.